ETM Experimental and Therapeutic Medicine 1792-0981 1792-1015 D.A. Spandidos ETM-27-6-12544 10.3892/etm.2024.12544 Articles Dandelion root extracts and taraxasterol inhibit LPS‑induced colorectal cancer cell viability by blocking TLR4‑NFκB‑driven ACE2 and TMPRSS2 pathways YangKerry 1 WangYuehong 2 3 Faculty of Health Sciences, McMaster University, Hamilton, Ontario L8S 4L8, Canada Cardiovascular and Metabolic Research Unit, Laurentian University, Sudbury, Ontario P3E 2C6, Canada State Key Laboratory of Systems Medicine for Cancer, School of Medicine, Shanghai Jiao Tong University, Shanghai 200240, P.R. China Correspondence to: Dr Yuehong Wang, State Key Laboratory of Systems Medicine for Cancer, School of Medicine, Shanghai Jiao Tong University, 800 Dongchuan Road, Minhang, Shanghai 200240, P.R. China cyan0515@163.com wangyh-0327@hotmail.com

Abbreviations: ACE2, angiotensin-converting enzyme 2; LPS, lipopolysaccharide; siRNA, small interfering RNA; TLR4, toll-like receptor 4; TMPRSS2, transmembrane serine protease 2

 06 2024 19 04 2024 27 6 256 05 09 2023 14 03 2024 Copyright: © 2024 Yang and Wang. 2024 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Colorectal cancer is the fourth leading cause of cancer-related death worldwide. Notably, abnormalities in intestinal bacteria may contribute to the initiation or progression of colorectal cancer. Lipopolysaccharide (LPS), a bacterial endotoxin, is elevated in patients with colorectal cancer. The present study investigated the protective effects of dandelion root extracts and taraxasterol (TS; a major pharmacologically active compound in dandelion root extracts) on LPS-induced colorectal cancer cell viability, as well as the underlying mechanisms. Cell viability was assessed by MTT assay, and protein and gene expression levels were determined by western blotting and quantitative PCR. It was revealed that LPS at a low dose (0.5 µg/ml) significantly promoted the viability of human colorectal cancer cells but did not affect normal colon epithelial cells. The addition of dandelion root extracts (0.1-1 mg/ml) or TS (0.05-1 µg/ml) was able to reverse the LPS-induced increase in colorectal cancer cell viability and colony formation. Mechanistically, dandelion root extracts or TS may inhibit the LPS-promoted toll-like receptor 4 (TLR4)/NFκB-p65 pathway and transcription levels of pro-inflammatory genes (TNFα, IL4 and IL6). Compared with normal colon epithelial cells, human colorectal cancer cells had higher expression levels of angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2), which could be further enhanced by LPS treatment but this was reversed by co-incubation with dandelion root extracts or TS. In addition, suppression of the TLR4/NFκB-p65 pathway with CLI095 significantly reversed the stimulatory effect of LPS on the expression levels of ACE2 and TMPRSS2, whereas TNFα (10 ng/ml) markedly induced the expression levels of ACE2 and TMPRSS2. In conclusion, the present study suggested that dandelion root extracts and TS could be used as prevention strategies for reversing bacteria-driven colorectal cancer cell viability.

 dandelion root extracts taraxasterol LPS TLR4/ NFκB-p65 ACE2/TMPRSS2 Funding: No funding was received. Introduction

Colorectal cancer is the fourth leading cause of cancer-related death worldwide, and the incidence of colorectal cancer has increased rapidly in the past few years (1). According to the World Health Organization, >1.9 million new cases of colorectal cancer and approximately 1 million deaths due to colorectal cancer occurred worldwide in 2020. Several risk factors are associated with the initiation and progression of colorectal cancer, including age, sex, ethnicity, dietary habits, colon polyps and long-lasting ulcerative colitis (2,3). There is a growing body of evidence suggesting that the high density of bacteria in the colon serves an important role in colorectal cancer tumorigenesis (4-6). The gut microbiota is vital for human health through the regulation of food digestion and energy metabolism, maintenance of gut homeostasis, and modulation of host immunity (7,8). However, abnormalities in the intestinal microbiota composition caused by lifestyle habits, food intake, age and/or environmental factors may lead to an imbalance in bacterial populations, thus resulting in the overproduction of pro-inflammatory and pro-carcinogenic toxins that promote colorectal carcinogenesis (5,9,10). Lipopolysaccharide (LPS) is a bacterial endotoxin and a highly potent pro-inflammatory molecule, which is often implicated in tumorigenesis (11,12). LPS has been reported to be elevated in patients with colorectal cancer (13-15). The binding of LPS to toll-like receptor 4 (TLR4) in intestinal epithelial cells activates the NFκB pathway, resulting in increased expression and secretion of pro-inflammatory mediators, and contributing to the occurrence, development and metastasis of various tumors, including colorectal cancer and liver tumors (16,17).

The receptor angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) are abundantly expressed in the colon, and have been shown to be upregulated in human colon carcinoma (18-20). LPS and some cytokines (TNFα, IL4 and IL6) can alter the expression levels and activities of ACE2 and TMPRSS2(21). ACE2 and TMPRSS2 are also known as host proteins for the entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into human cells causing COVID-19(22), and blockage of ACE2 or TMPRSS2 can suppress the infection of human epithelial cells with SARS-CoV-2(23). Notably, patients with colorectal cancer are more likely to develop severe gastrointestinal symptoms and experience an increased risk of death compared with healthy individuals infected with SARS-CoV-2 (20,24). These findings indicate a potential association between ACE2 and TMPRSS2 and colorectal cancer.

Dandelions have been used as a popular herbal medicine for centuries, and have been reported to protect against inflammation, digestive diseases and cancer (25,26). Dandelion root extracts have been shown to selectively suppress colorectal cancer cell proliferation but have no detrimental effects on normal colon epithelial cells (27). In addition, dandelion root extract has been shown to protect against stress-induced colitis in mice (28). Phytochemical analysis has identified taraxasterol (TS) as a pharmacologically active compound obtained from dandelion root extracts, which may reduce colorectal cancer cell viability and inhibit colonic epithelial cell inflammation (27,29). In addition, TS has been widely reported to attenuate LPS-induced oxidative stress and inflammation in in vitro cell culture and in vivo animal models (30-32). However, to the best of our knowledge, the regulatory roles of dandelion root extracts and TS in bacteria-driven colorectal cancer cell viability have not been investigated. The present study explored the protective effects of dandelion root extracts and TS on LPS-induced colorectal cancer cell viability, as well as the underlying mechanisms.

 Materials and methods <sec> <title>Preparation of dandelion root extracts

Dandelions (Taraxacum officinale) were collected from yards and fields in Sudbury (latitude 46.4917˚ N; longitude 80.9930˚ W), Ontario, Canada. The water extracts of dandelion roots were prepared as described previously (33). Briefly, the air-dried dandelion roots were extracted in boiling water for 4 h. The extracts were first filtered through Whatman filter paper and concentrated. The dried extracts were then weighed and dissolved in distilled water followed by filtration through a 0.2-µm filter. Finally, the aqueous extracts of dandelion roots were stored at 4˚C for the following experiments.

 Cell culture

Human colorectal cancer cells (WiDr; cat. no. CCL-218) and normal intestinal epithelial cells (FHC; cat. no. CRL-1831) were purchased from American Type Culture Collection. According to the information from American Type Culture Collection, DNA fingerprinting has shown WiDr cells to be a derivative of the HT-29 cell line (cat. no. HTB-38), which was originally isolated from the colon of a female patient with colorectal adenocarcinoma. The cells were incubated in Dulbecco's modified Eagle's medium (MilliporeSigma) supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 100 µg/ml streptomycin (all Thermo Fisher Scientific, Inc.) in a humidified atmosphere of 5% CO2 at 37˚C. The experiments were performed when the cells reached 70-80% confluence.

 Cell viability assay

Cell viability was assessed using the MTT assay as described previously (34). In this assay, the living cells can convert MTT to purple formazan crystals. Briefly, equal numbers of cells (1x104) were seeded in each well of a 96-well plate for 24 h. After the cells were treated with dandelion root extracts (0.01-1 mg/ml), TS (0.01-1 µg/ml), LPS (0.1-10 µg/ml) and/or TFNα (1-20 ng/ml) for 24 h at 37˚C, MTT (0.5 mg/ml) was added to each well and the cells were then cultured at 37˚C for an additional 4 h, after which, 100 µl dimethyl sulfoxide was added for 5 min to dissolve the purple formazan. The absorbance at 570 nm was measured using a FLUOstar OPTIMA microplate reader (BMG Labtech GmbH). The control cells without any treatment were considered 100% viable.

 Colony formation assay

Human colorectal cancer cells (1x105) were treated with or without 0.5 µg/ml LPS (MilliporeSigma) for 24 h at 37˚C. Subsequently, the medium was discarded, and fresh medium containing root extracts (0.1 mg/ml) or TS (0.1 µg/ml; MilliporeSigma) was added for an additional 14 days at 37˚C. Afterwards, the medium was aspirated and the cells were fixed with cold 100% methanol for 10 min at room temperature. The cells were then stained with 0.01% crystal violet for 60 min at room temperature. After washing with PBS, images of the plates were captured to count the number of colonies formed using ImageJ 1.43 software (National Institutes of Health). Clusters of ≥50 cells were considered a colony.

 Detection of protein expression levels by western blotting

After the cells were treated with dandelion root extracts (0.1 mg/ml), TS (0.01 µg/ml), LPS (0.5 µg/ml), TNFα (10 ng/ml) and/or CLI095 (10 µM) for 24 h at 37˚C, the cultured cells were collected for protein analysis by western blotting as described previously (34,35). Briefly, the cells were lysed with radioimmunoprecipitation assay buffer supplemented with a protease inhibitor cocktail (MilliporeSigma) for protein extraction. Protein concentrations were determined with BCA assays (Thermo Fisher Scientific, Inc.). Equal amounts of proteins (90 µg/well) were then separated by SDS-PAGE on 10% gels and were transferred to nitrocellulose membranes (Pall Corporation). The membranes were first blocked with PBS-0.1% Tween 20 containing 3% skim milk at 4˚C overnight. The membranes were then incubated with appropriate primary antibodies for 90 min at room temperature. The following primary antibodies were used: TLR4 (cat. no. 38519; 1:1,000; Cell Signaling Technology, Inc.), NFκB-p65 (cat. no. 8242; 1:1,000; Cell Signaling Technology, Inc.), ACE2 (cat. no. 4355; 1:1,000; Cell Signaling Technology, Inc.), TMPRSS2 (cat. no. PAB11593; 1:1,000; Abnova) and GAPDH (cat. no. 97166; 1:5,000; Cell Signaling Technology, Inc.). After 3 times washing with PBS-0.1% Tween 20 containing 3% skim milk, the membranes were incubated with peroxidase-conjugated secondary antibodies (cat. no. AP132P or AP160P; 1:5,000; MilliporeSigma) for 90 min at room temperature followed by 3 times washing with PBS-0.1% Tween 20. The protein bands in the membranes were then visualized using ECL solution (Bio-Rad Laboratories, Inc.) in a dark room with an X-ray film. The densitometry of the band for each target protein was analyzed using ImageJ 1.43 software by normalizing to the intensity of GAPDH.

 Analysis of mRNA expression levels by reverse transcription- quantitative PCR (qPCR)

After the cells were treated with LPS (0.5 µg/ml) with or without dandelion root extracts (0.1 mg/ml) and TS (0.01 µg/ml) for 24 h at 37˚C, the cells were collected for isolation of total RNA using TRI reagent (MilliporeSigma). The RNAs were reversed transcribed to cDNA using a Verso cDNA synthesis kit according to the manufacturer's instructions (Thermo Fisher Scientific, Inc.). The mRNA expression levels were quantified with SYBR Green PCR Master Mix (Thermo Fisher Scientific, Inc.) using a CFX Real-Time PCR Detection System (Bio-Rad Laboratories, Inc.). Samples that were not treated with reverse transcriptase were included as negative controls of genomic DNA contamination. The following primers were used in the present study: TNFα forward, 5'-GGGCTCCAGGCGGTGCTTGTTC-3' and reverse, 5'-GCGGCTGATGGTGTGGGTGAGG-3'; IL4 forward, 5'-ACTGCTTCCCCCTCTGTTCTTCC-3' and reverse, 5'-GAGGTTCCTGTCGAGCCGTTTCA-3'; IL6 forward, 5'-AAAGAGGCACTGGCAGAAAACAAC-3' and reverse, 5'-TTAAAGCTGCGCAGAATGAGATGA-3'; ACE2 forward, 5'-CCGCGGCCAGTTGATTGA-3' and reverse, 5'-ACATTTCCTGGGTCCGTTAGCAT-3'; TMPRSS2 forward, 5'-CACGCAGCCCAAATCCCCATCC-3' and reverse, 5'-GCCGCCCGCCCGTAGTTCTC-3'; and GAPDH forward, 5'-CGGGGCTCTCCAGAACATCAT-3' and reverse, 5'-CCAGCCCCAGCGTCAAAGGTG-3'. The qPCR program was as follows: One cycle at 94˚C for 5 min, 35 cycles at 94˚C for 20 sec, 62˚C for 30 sec and 72˚C for 30 sec, and a final step for melting curve determination (94˚C for 15 sec, increasing from 60˚C to 94˚C in 0.5˚C/15 sec increments). Relative mRNA quantification was performed using the 2-ΔΔCq formula (36) by normalizing to the endogenous reference gene GAPDH.

 Small interfering RNA (siRNA) transfection

The knockdown of ACE2 and TMPRSS2 was conducted using pre-designed siRNAs from Santa Cruz Biotechnology, Inc. A control-siRNA (cat. no. sc-37007) with a scrambled sequence that would not lead to the specific degradation of any cellular messages acted as a non-targeting control. ACE2-siRNA (cat. no. sc-41400) and TMPRSS2-siRNA (cat. no. sc-41658) consisted of pools of three to five target-specific 19-25 nucleotide sequences. Transfection of the cells with siRNAs was achieved using Lipofectamine® 2000 (Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol. Briefly, the cells were plated overnight to form 60-70% confluent monolayers. After colorectal cancer cells were transfected with control siRNA (100 nM) or ACE2 siRNA/TMPRSS2 siRNA (100 nM) for 24 h at 37˚C, the cells were then incubated with LPS (0.5 µg/ml) and/or CLI095 (10 µM) for additional 24 h at 37˚C.

 Statistical analysis

Data are presented as the mean ± standard error of at least three independent experimental repeats. Statistical analyses were conducted using SPSS 21.0 software (IBM Corp.). Unpaired Student's t-test was applied to analyze statistically significant differences between two groups, and one-way analysis of variance followed by the Tukey's test was used to analyze differences among more than two groups. P<0.05 was considered to indicate a statistically significant difference.

 Results <sec> <title>Dandelion root extracts and TS inhibit the LPS-induced viability of colorectal cancer cells

When both human colorectal cancer cells and normal epithelial cells were incubated with either dandelion root extracts (0-1 mg/ml) or TS (0-1 µg/ml) for 24 h, the cell viabilities were not changed compared with those of the control cells without any treatment (Fig. 1A and B). The cell viability of control cells was set at 100%, and subsequently, it was shown that LPS at a low concentration (0.5 µg/ml) significantly enhanced the viability of colorectal cancer cells by 32%, whereas a lower (0.1 µg/ml) or higher dose (1, 5 and 10 µg/ml) of LPS had no effect on the viability of colorectal cancer cells (Fig. 2A). LPS at all tested doses (0.1, 0.5, 1, 5 and 10 µg/ml) did not affect the viability of normal epithelial cells. The addition of dandelion root extracts at a concentration of >0.1 mg/ml (Fig. 2B) or TS at concentration of >0.05 µg/ml (Fig. 2C) significantly suppressed the stimulatory effect of LPS (0.5 µg/ml) on the viability of colorectal cancer cells. Increasing the concentration of dandelion root extracts to 0.5 and 1 mg/ml, or the concentration of TS to 0.1, 0.5 and 1 µg/ml did not further inhibit LPS-induced cell viability. By contrast, dandelion root extracts at a concentration <0.1 mg/ml or TS at a concentration <0.05 µg/ml had no effect on LPS-induced cell viability (0.5 µg/ml). Therefore, in the following experiments, the concentrations of dandelion root extracts and TS were chosen as 0.1 mg/ml and 0.1 µg/ml, since both doses were able to bring the cell viability to the basal level. It was further observed that the number of colonies formed in LPS (0.5 µg/ml)-treated colorectal cancer cells was 1.6 times that formed in the control cells, which was significantly reduced by co-incubation with root extracts (0.1 mg/ml) or TS (0.1 µg/ml) for 14 days (Fig. 2D). Root extracts or TS alone had no effect on colony formation in comparison with the control cells.

 Dandelion root extracts and TS inhibit LPS-stimulated TLR4/NFκB-p65 signaling

LPS (0.5 µg/ml) significantly increased the protein expression levels of TLR4 and NFκB-p65, and the supplementation of dandelion root extracts (0.1 mg/ml) or TS (0.1 µg/ml) decreased the expression levels of NFκB-p65 but not TLR4 (Fig. 3A). The dandelion root extracts or TS alone had no effect on the protein expression levels of TLR4 and NFκB-p65. As shown in Fig. 3B, LPS (0.5 µg/ml) markedly increased the mRNA expression levels of TNFα, IL4 and IL6, which could be significantly inhibited by the supplementation of dandelion root extracts (0.1 mg/ml) or TS (0.1 µg/ml).

 Dandelion root extracts and TS suppress LPS-induced ACE2 and TMPRSS2 expression

ACE2 and TMPRSS2 were expressed in both normal epithelial cells and colorectal cancer cells (Fig. 4A). Compared with those in normal epithelial cells, the protein expression levels of ACE2 and TMPRSS2 were significantly higher in colorectal cancer cells. Dandelion root extracts or TS alone had no effect on the protein expression levels of ACE2 and TMPRSS2 in colorectal cancer cells (Fig. 4B). By contrast, LPS (0.5 µg/ml) significantly increased the protein expression levels of ACE2 and TMPRSS2, which could be blocked by the addition of dandelion root extracts (0.1 mg/ml) or TS (0.1 µg/ml) in colorectal cancer cells (Fig. 4C). Similarly, the mRNA expression levels of ACE2 and TMPRSS2 were markedly increased in LPS-treated colorectal cancer cells, whereas co-incubation with dandelion root extracts and TS suppressed the LPS-induced increase in ACE2 and TMPRSS2 transcript levels (Fig. 4D).

 Blockage of TLR4/NFκB signaling attenuates LPS-induced ACE2/TMPRSS2 expression and LPS/TNFα-induced cell viability

Incubation of colorectal cancer cells with 10 µM CLI095, a TLR4 signaling inhibitor, significantly reversed the LPS-induced increase in the expression levels of ACE2 and TMPRSS2 (Fig. 5A). By contrast, treatment with TNFα, a downstream molecule of TLR4/NFκB, significantly increased the protein and mRNA expression levels of ACE2 and TMPRSS2 (Fig. 5B and C). Furthermore, in comparison to the control cells, TNFα at 5, 10 and 20 ng/ml, but not 15 ng/ml, significantly stimulated the viability of colorectal cancer cells, which could be reduced by co-incubation with dandelion root extracts (0.1 mg/ml) or TS (0.1 µg/ml) (Fig. 5D). To explore the involvement of ACE2/TMPRSS2 in LPS-induced cancer cell viability, siRNAs were used to knock down ACE2 and TMPRSS2. Knockdown was confirmed at both the mRNA (Fig. 6A and C) and protein levels (Fig. 6B and D). Either siRNA-mediated knockdown of ACE2/TMPRSS2 or blockage of TLR4/NFκB signaling by CLI095 suppressed LPS-stimulated colorectal cancer cell viability (Fig. 6E). These data suggested that ACE2 and TMPRSS2 are the downstream targets of TLR4/NFκB/proinflammatory cytokines, and TLR4/NFκB-driven ACE2/TMPRSS2 pathways may mediate the stimulatory role of LPS in colorectal cancer cell viability.

 Discussion

Colorectal cancer is one of the major causes of cancer mortality worldwide. The pathogenesis of colorectal cancer is highly diverse and complex (2,3). Evidence has demonstrated that abnormalities in intestinal bacteria may contribute to the initiation or progression of colorectal cancer (1,6,10). Dandelion roots have been used as a traditional herbal medicine for thousands of years, and have been reported to protect against inflammation, digestive diseases and cancer (25,26). The present study explored the protective effects of dandelion root extracts, and the major active component TS, against LPS-stimulated colorectal cancer cell viability.

The colon is continuously exposed to bacteria, and alterations in the gut microbiota and bacteria-derived LPS endotoxin may have a direct effect on the initiation and progression of colorectal cancer by inducing chronic inflammation, DNA damage and genetic instability (11,37). It has been demonstrated that circulating levels of LPS are markedly higher in patients with colorectal cancer (14,15). Using an MTT assay, the present study revealed that the viability of 0.5 µg/ml LPS-treated cells (132%) was significantly higher than that of the control cells (100%), suggesting that LPS at 0.5 µg/ml may promote cell viability. Notably, the increased cell viability does not necessarily indicate cancer induction. To further explore this, a clonogenic assay was conducted to explore whether LPS at 0.5 µg/ml could promote a single cell to grow into a colony during a period of 2 weeks. It was confirmed that LPS at 0.5 µg/ml induced colony formation, indicating the carcinogenic role of LPS.

The present study subsequently demonstrated that dandelion root extracts or TS could inhibit LPS-induced colorectal cancer cell viability and colony formation. TS is a major pharmacologically active compound in dandelion root extracts. Dandelion extracts and TS have been extensively studied for their anti-inflammatory and anticancer effects (25,26,30-32). In addition, as determined in the present study, incubation of human colorectal cancer cells and normal colon epithelial cells with dandelion root extracts at concentrations ≤1 mg/ml for 24 h did not affect their viability. Ovadje et al (27) observed that colorectal cancer cell proliferation was only inhibited following 96-h treatment with dandelion root extracts at concentrations ≥1.5 mg/ml, indicating that the inhibitory effect of dandelion root extracts on cancer cell viability is time- and dose-dependent. Dandelion root extracts have also been shown to protect against dextran sodium sulfate-induced colonocyte damage, thus indicating the anti-colitis potential of dandelion root extracts (28). In addition, dandelion root extracts and TS have been reported to attenuate the antibiotic resistance of bacteria, which may also contribute to the inhibition of colorectal cancer cell proliferation due to a lower level of colorectal cancer-driving bacteria and genotoxins (38). These data suggested that regular intake of dietary dandelion may be helpful for gut health and inhibition of colorectal cancer development.

The present study also assessed the mechanisms underlying LPS-induced colorectal cancer cell viability. TLR4/NFκB signaling is often involved in the cell immune response, tumorigenesis and cancer progression (39). Interventions in TLR4/NFκB signaling have been demonstrated to be effective in cancer prevention and treatment (40,41). A growing body of evidence has shown that the TLR4/NFκB pathway is primarily responsible for the initiation of pro-inflammatory responses by LPS (16,42). The present study also confirmed that LPS activated TLR4/NFκB signaling and induced the transcription of several pro-inflammatory cytokines, including TNFα, IL4 and IL6. Similar to LPS, the presence of TNFα could induce increased colorectal cancer cell viability. By contrast, blockage of the TLR4/NFκB pathway by CLI095 markedly abolished the stimulatory effect of LPS on colorectal cancer cell viability. These data suggested that LPS-activated TLR4/NFκB signaling may contribute to increased colorectal cancer cell viability. Future studies should identify the molecular mechanisms underlying the inhibition of the LPS-induced TLR4/NFκB pathway by dandelion root extracts or TS.

The present study further revealed that ACE2 and TMPRSS2 were more highly expressed in colorectal cancer cells than in normal epithelial cells, and their expression levels could be upregulated by LPS. Both ACE2 and TMPRSS2 also mediated the inhibitory roles of dandelion root extracts and TS on LPS-induced colorectal cancer cell viability, as knockdown of either ACE2 or TMPRSS2 suppressed LPS-induced cell viability. The regulatory effects of LPS on ACE2 have been widely reported. ACE2 expression has been shown to be increased in a mouse model of LPS-induced lung fibrosis, whereas the ACE2 activator diminazene aceturate reduced pulmonary fibrosis, indicating the potential value of targeting ACE2 for healing lung fibrosis (43). Abdelhamid et al (13) revealed that xanthenone treatment reversed LPS-induced acute respiratory distress syndrome in mice by modulating ACE2 expression. ACE2 and TMPRSS2 have also been observed to be highly expressed in various types of cancer, including colorectal, stomach, pancreatic and prostate cancer (44). ACE2 expression was also upregulated in patients with gastric cancer who had different stages of tumor invasion depth (24,45). However, the functional roles of ACE2 and TMPRSS2 in tumorigenesis remain unclear and require further mechanistic studies. In addition, patients with colorectal cancer may be particularly susceptible to SARS-CoV-2 infection due to higher expression levels of ACE2 and TMPRSS2 (20,24). Notably, Tran et al (46) reported that dandelion leaf aqueous extracts can block the protein-protein interaction between the SARS-CoV-2 spike protein and the ACE2 receptor. It is thus predicted that dandelion extracts may be used for prevention of SARS-CoV-2 infection.

The present study also examined how LPS enhanced ACE2 and TMPRSS2 expression. It was revealed that TLR4/NFκB signals may act upstream of ACE2/TMPRSS2, which was supported by two pieces of evidence. First, blockage of TLR4 with CLI095 significantly reversed the stimulatory effect of LPS on the expression levels of ACE2 and TMPRSS2. Second, TNFα, a downstream molecule of TLR4/NFκB, markedly increased the expression levels of ACE2 and TMPRSS2 at both the mRNA and protein levels. By contrast, Zhang et al (47) reported that high levels of ACE2 can protect against LPS-induced inflammation in bovine mammary epithelial cells by inhibiting the NFκB pathway. It has also been reported that LPS caused inflammatory damage in porcine intestinal epithelial cells (IPEC-J2) by inactivating ACE2 and stimulating pro-inflammatory cytokines (TNFα, IL1β and IL8), whereas knockdown of the ACE2 gene increased TLR4 expression and aggravated the inflammatory response (43). These data suggested that the LPS-induced interaction between TLR4/NFκB and ACE2 is complex, and ACE2 may serve a dual role in regulating the inflammatory response depending on the cell type, and the dose and duration of LPS treatment. The identification of the missing links between TLR4/NFκB/inflammatory cytokines and the ACE2/TMPRSS2 cascade will lead to an improved understanding of the association between ACE2/TMPRSS2 and the pathogenesis of colorectal cancer.

In conclusion, the present study revealed that LPS (0.5 µg/ml) had a significant stimulatory effect on the viability of human colorectal cancer cells but did not affect normal epithelial cells. Dandelion root extracts at concentrations ≥0.1 mg/ml or TS at concentrations ≥0.05 µg/ml were able to reverse the LPS-induced increase in colorectal cancer cell viability and colony formation via interruption of TLR4/NFκB/inflammatory cytokines/ACE2/TMPRSS2 pathways. Thus, the in vitro results from the present study suggested that dandelion root extracts and TS could be used as preventative strategies for reversing bacteria-increased colorectal cancer cell viability (Fig. 7). Further research using animal models and a human trial to assess the clinical relevance of dandelion root extracts should be encouraged.

 Acknowledgements

Not applicable.

 Availability of data and materials

The data generated in the present study may be requested from the corresponding author.

 Authors' contributions

KY and YW were responsible for the study design, and acquisition and interpretation of data. KY and YW wrote the article. Each author agrees to the author's own contributions and to the integrity and accuracy of the work. KY and YW confirm the authenticity of all the raw data. Both authors read and approved the final manuscript.

 Ethics approval and consent to participate

Not applicable.

 Patient consent for publication

Not applicable.

 Competing interests

The authors declare that they have no competing interests.

 References ReisSADda ConceiçãoLLPeluzioMDCGIntestinal microbiota and colorectal cancer: Changes in the intestinal microenvironment and their relation to the diseaseJ Med Microbiol681391140720193142438210.1099/jmm.0.001049 MaryamSKrukiewiczKHaqIUKhanAAYahyaGCavaluSInterleukins (cytokines) as biomarkers in colorectal cancer: Progression, detection, and monitoringJ Clin Med12312720233717656710.3390/jcm12093127 HofsethLJHebertJRChandaAChenHLoveBLPenaMMMurphyEASajishMShethABuckhaultsPJBergerFGEarly-onset colorectal cancer: Initial clues and current viewsNat Rev Gastroenterol Hepatol1735236420203208649910.1038/s41575-019-0253-4 CollinsDHoganAMWinterDCMicrobial and viral pathogens in colorectal cancerLancet Oncol1250451220112106797310.1016/S1470-2045(10)70186-8 de WaalGMde VilliersWJSForganTRobertsTPretoriusEColorectal cancer is associated with increased circulating lipopolysaccharide, inflammation and hypercoagulabilitySci Rep10877720203247208010.1038/s41598-020-65324-2 TjalsmaHBoleijAMarchesiJRDutilhBEA bacterial driver-passenger model for colorectal cancer: Beyond the usual suspectsNat Rev Microbiol1057558220122272858710.1038/nrmicro2819 LucasCBarnichNNguyenHTTMicrobiota, inflammation and colorectal cancerInt J Mol Sci18131020172863215510.3390/ijms18061310 ChuFFEsworthyRSChuPGLongmateJAHuyckeMMWilczynskiSDoroshowJHBacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genesCancer Res6496296820041487182610.1158/0008-5472.can-03-2272 PandeyHTangDWTWongSHLalDGut microbiota in colorectal cancer: Biological role and therapeutic opportunitiesCancers (Basel)1586620233676582410.3390/cancers15030866 MandalPMolecular mechanistic pathway of colorectal carcinogenesis associated with intestinal microbiotaAnaerobe49637020182927762310.1016/j.anaerobe.2017.12.008 KasaiCSugimotoKMoritaniITanakaJOyaYInoueHTamedaMShirakiKItoMTakeiYTakaseKComparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: Terminal restriction fragment length polymorphism and next-generation sequencing analysesOncol Rep3532533320162654977510.3892/or.2015.4398 PitariGMZingmanLVHodgsonDMAlekseevAEKazerounianSBienengraeberMHajnóczkyGTerzicAWaldmanSABacterial enterotoxins are associated with resistance to colon cancerProc Natl Acad Sci USA1002695269920031259433210.1073/pnas.0434905100 AbdelhamidAMDeebMEZaafanMAThe protective effect of xanthenone against LPS-induced COVID-19 acute respiratory distress syndrome (ARDS) by modulating the ACE2/Ang-1-7 signaling pathwayEur Rev Med Pharmacol Sci265285529620223591682910.26355/eurrev_202207_29320 SeoGSThe role of NF-kappaB in colon cancerKorean J Gastroenterol573720112125819410.4166/kjg.2011.57.1.3(In Korean) O'LearyDPBhattLWoolleyJFGoughDRWangJHCotterTGRedmondHPTLR-4 signalling accelerates colon cancer cell adhesion via NF-κB mediated transcriptional up-regulation of Nox-1PLoS One7e4417620122307149310.1371/journal.pone.0044176 KilleenSDWangJHAndrewsEJRedmondHPBacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-kappaB-dependent activation of the urokinase plasminogen activator systemBr J Cancer1001589160220091943630610.1038/sj.bjc.6604942 RannehYAkimAMHamidHAKhazaaiHFadelAMahmoudAMStingless bee honey protects against lipopolysaccharide induced-chronic subclinical systemic inflammation and oxidative stress by modulating Nrf2, NF-κB and p38 MAPKNutr Metab (Lond)161520193085886910.1186/s12986-019-0341-z AnXLinWLiuHZhongWZhangXZhuYWangXLiJShengQSARS-CoV-2 host receptor ACE2 protein expression atlas in human gastrointestinal tractFront Cell Dev Biol965980920213417898510.3389/fcell.2021.659809 BernardiSZennaroCPalmisanoSVelkoskaESabatoNToffoliBGiacomelGBuriLZanconatiFBelliniGCharacterization and significance of ACE2 and Mas receptor in human colon adenocarcinomaJ Renin Angiotensin Aldosterone Syst1320220920122204894810.1177/1470320311426023 LiuCWangKZhangMHuXHuTLiuYHuQWuSYueJHigh expression of ACE2 and TMPRSS2 and clinical characteristics of COVID-19 in colorectal cancer patientsNPJ Precis Oncol5120213347950610.1038/s41698-020-00139-y Reindl-SchwaighoferREskandaryFBartkoJHeinzelAJilmaBHeckingMSchoergenhoferCCorticosteroid treatment prevents lipopolysaccharide-induced increase of ACE2 and reduces fibrin degradation products in bronchoalveolar lavage fluidFront Med (Lausanne)985689120223530853510.3389/fmed.2022.856891 BurgueñoJFReichAHazimeHQuinteroMAFernandezIFritschJSantanderAMBritoNDamasOMDeshpandeAExpression of SARS-CoV-2 entry molecules ACE2 and TMPRSS2 in the gut of patients with IBDInflamm Bowel Dis2679780820203233360110.1093/ibd/izaa085 ZabiegalaAKimYChangKORoles of host proteases in the entry of SARS-CoV-2Anim Dis31220233712850810.1186/s44149-023-00075-x AhmadiMPashangzadehSMousaviPSaffarzadehNHabibiMAHajiesmaeiliFRezaeiNACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19Int Immunopharmacol9510756820213376561210.1016/j.intimp.2021.107568 HfaiedhMBrahmiDZourguiLHepatoprotective effect of Taraxacum officinale leaf extract on sodium dichromate-induced liver injury in ratsEnviron Toxicol3133934920162527067710.1002/tox.22048 SigstedtSCHootenCJCallewaertMCJenkinsARRomeroAEPullinMJKornienkoALowreyTKSlambrouckSVSteelantWFEvaluation of aqueous extracts of Taraxacum officinale on growth and invasion of breast and prostate cancer cellsInt J Oncol3210851090200818425335 OvadjePAmmarSGuerreroJAArnasonJTPandeySDandelion root extract affects colorectal cancer proliferation and survival through the activation of multiple death signalling pathwaysOncotarget7730807310020162756425810.18632/oncotarget.11485 DingAWenXDandelion root extract protects NCM460 colonic cells and relieves experimental mouse colitisJ Nat Med7285786620182974073510.1007/s11418-018-1217-7 SharmaKZafarROccurrence of taraxerol and taraxasterol in medicinal plantsPharmacogn Rev9192320152600968810.4103/0973-7847.156317 LiuBHeZWangJXinZWangJLiFFuYTaraxasterol inhibits LPS-induced inflammatory response in BV2 microglia cells by activating LXRαFront Pharmacol927820182967052610.3389/fphar.2018.00278 CheLLiYSongRQinCHaoWWangBYangLPengPXuFAnti-inflammatory and anti-apoptosis activity of taraxasterol in ulcerative colitis in vitro and in vivoExp Ther Med181745175120193141013310.3892/etm.2019.7736 ZhangXXiongHLiHChengYProtective effect of taraxasterol against LPS-induced endotoxic shock by modulating inflammatory responses in miceImmunopharmacol Immunotoxicol36111620142428637010.3109/08923973.2013.861482 ChoSYParkJYParkEMChoiMSLeeMKJeonSMJangMKKimMJParkYBAlternation of hepatic antioxidant enzyme activities and lipid profile in streptozotocin-induced diabetic rats by supplementation of dandelion water extractClin Chim Acta31710911720021181446510.1016/s0009-8981(01)00762-8 BarrowKWangYYuRZhuJYangGH2S protects from oxidative stress-driven ACE2 expression and cardiac agingMol Cell Biochem4771393140320223514790210.1007/s11010-022-04386-4 LiLLiMLiYSunWWangYBaiSLiHWuBYangGWangRExogenous H2S contributes to recovery of ischemic post-conditioning-induced cardioprotection by decrease of ROS level via down-regulation of NF-κB and JAK2-STAT3 pathways in the aging cardiomyocytesCell Biosci62620162709607410.1186/s13578-016-0090-x LivakKJSchmittgenTDAnalysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) methodMethods2540240820011184660910.1006/meth.2001.1262 YangYYangLJiangSYangTLanJLeiYTanHPanKHMGB1 mediates lipopolysaccharide-induced inflammation via interacting with GPX4 in colon cancer cellsCancer Cell Int2020520203251425010.1186/s12935-020-01289-6 YangKZhangYReversal of heavy metal-induced antibiotic resistance by dandelion root extracts and taraxasterolJ Med Microbiol691049106120203260283210.1099/jmm.0.001226 SunQLiuQZhengYCaoXRapamycin suppresses TLR4-triggered IL-6 and PGE(2) production of colon cancer cells by inhibiting TLR4 expression and NF-kappaB activationMol Immunol452929293620081834350210.1016/j.molimm.2008.01.025 YingJZhouHWangZYouQChenJLuHZhangJAspirin increases chemosensitivity of colorectal cancer cells and inhibits the expression of toll-like receptor 4Cancer Cell Int23620233664707110.1186/s12935-023-02847-4 ZhuoQYuBZhouJZhangJZhangRXieJWangQZhaoSLysates of Lactobacillus acidophilus combined with CTLA-4-blocking antibodies enhance antitumor immunity in a mouse colon cancer modelSci Rep92012820193188286810.1038/s41598-019-56661-y LiZWangKJiXWangHZhangYACE2 suppresses the inflammatory response in LPS-induced porcine intestinal epithelial cells via regulating the NF-κB and MAPK pathwaysPeptides14917071720223493300910.1016/j.peptides.2021.170717 LinXLinWZhuangYGaoFAngiotensin-converting enzyme 2 inhibits lipopolysaccharide-caused lung fibrosis via downregulating the transforming growth factor β-1/Smad2/Smad3 pathwayJ Pharmacol Exp Ther38123624620223534706310.1124/jpet.121.000907 ChengJZhouJFuSFuJZhouBChenHFuJWeiCProstate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2J Cell Mol Med254157416520213360906910.1111/jcmm.16385 KloosterJPTBol-SchoenmakersMvan SummerenKvan VlietALWde HaanCAMvan KuppeveldFJMVerkoeijenSPietersREnterocytes, fibroblasts and myeloid cells synergize in anti-bacterial and anti-viral pathways with IL22 as the central cytokineCommun Biol463120213404564010.1038/s42003-021-02176-0 TranHTTGiglMLeNPKDawidCLamyEIn vitro effect of Taraxacum officinale leaf aqueous extract on the interaction between ACE2 cell surface receptor and SARS-CoV-2 spike protein D614 and four mutantsPharmaceuticals (Basel)14105520213468127910.3390/ph14101055 ZhangXJiaFMaWLiXZhouXDAD3 targets ACE2 to inhibit the MAPK and NF-κB signalling pathways and protect against LPS-induced inflammation in bovine mammary epithelial cellsVet Res5310420223648240410.1186/s13567-022-01122-0

Viability of colon cancer cells and normal epithelial cells is not affected by dandelion root extracts or TS. After colon cancer cells and normal epithelial cells were treated with (A) dandelion root extracts or (B) TS at the indicated concentrations for 24 h, cell viability was assessed using an MTT assay. n=4. TS, taraxasterol.

Dandelion root extracts and TS reverse the LPS-induced increase in viability of colon cancer cells. (A) LPS at 0.5 µg/ml induced the viability of colon cancer cells. After colon cancer cells and normal epithelial cells were treated with LPS (0-10 µg/ml) for 24 h, cell viability was assessed using an MTT assay. n=4. *P<0.05 vs. untreated control cells. (B) Dandelion root extracts (≥0.1 mg/ml) and (C) TS (≥0.05 µg/ml) reversed the LPS-induced increase in viability of colon cancer cells. After colon cancer cells were treated with LPS (0.5 µg/ml) with or without dandelion root extracts (0-1 mg/ml) or TS (0-1 µg/ml) for 24 h, the cell viability was assessed using an MTT assay. n=4. *P<0.05 vs. cells treated without LPS. (D) Dandelion root extracts and TS reversed LPS-induced colony formation. Human colon cancer cells were treated with or without 0.5 µg/ml LPS for 24 h followed by incubation with root extracts (0.1 mg/ml) or TS (0.1 µg/ml) for 14 days.n=3. *P<0.05 vs. untreated control cells; #P<0.05 vs. LPS only. LPS, lipopolysaccharide; TS, taraxasterol.

Dandelion root extracts and TS reverse the LPS-induced increase in the expression of NFκB-p65. After colorectal cancer cells were treated with LPS (0.5 µg/ml) with or without dandelion root extracts (0.1 mg/ml) or TS (0.1 µg/ml) for 24 h, the cells were collected for detection of (A) protein expression levels of TLR4 and NFκB-p65 by western blotting, and (B) inflammatory genes by reverse transcription-quantitative PCR. n=3. *P<0.05 vs. untreated control cells; #P<0.05 vs. LPS only. LPS, lipopolysaccharide; TLR4, toll-like receptor 4; TS, taraxasterol.

Dandelion root extracts and TS reverse the LPS-induced increase in expression levels of ACE2 and TMPRSS2. (A) Increased protein expression levels of ACE2 and TMPRSS2 in colorectal cancer cells, as analyzed by western blotting. n=3. *P<0.05 vs. normal epithelial cells. (B) Root extracts and TS had no effect on the protein expression levels of ACE2 and TMPRSS2 in colorectal cancer cells. After colorectal cancer cells were treated with dandelion root extracts (0.1 mg/ml) or TS (0.1 µg/ml) for 24 h, the cells were collected for detection of protein expression levels by western blotting. n=3. Root extracts and TS reversed the LPS-induced increase in (C) protein and (D) mRNA expression levels of ACE2 and TMPRSS2 in colorectal cancer cells. After colorectal cancer cells were treated with LPS (0.5 µg/ml) with or without dandelion root extracts (0.1 mg/ml) or TS (0.1 µg/ml) for 24 h, the cells were collected for detection of protein expression levels by western blotting, and detection of mRNA expression levels by reverse transcription-quantitative PCR. n=3. *P<0.05 vs. untreated control cells; #P<0.05 vs. LPS only. ACE2, angiotensin-converting enzyme 2; LPS, lipopolysaccharide; TMPRSS2, transmembrane serine protease 2; TS, taraxasterol.

LPS induces ACE2 and TMPRSS2 expression by promoting TLR4 and inflammatory gene expression in colon cancer cells. (A) Blockage of TLR4 by CLI095 attenuated LPS-induced ACE2 and TMPRSS2 protein expression in colorectal cancer cells. After colorectal cancer cells were incubated with LPS (0.5 µg/ml) with or without CLI095 (10 µM) for 24 h, the cells were collected for detection of protein expression levels by western blotting. n=3. *P<0.05 vs. untreated control cells; #P<0.05 vs. LPS only. TNFα induced ACE2 and TMPRSS2 (B) protein and (C) mRNA expression levels. After colorectal cancer cells were incubated with TNFα (10 ng/ml) for 24 h, the cells were collected for detection of protein expression levels by western blotting, and detection of mRNA expression levels by reverse transcription-quantitative PCR. n=3. *P<0.05 vs. untreated control cells. (D) Dandelion root extracts and TS reversed the TNFα-induced increase in cell viability. After colorectal cancer cells were incubated with TNFα (1-20 ng/ml) with or without dandelion root extracts (0.1 mg/ml) or TS (0.1 µg/ml) for 24 h, cell viability was analyzed using an MTT assay. n=4. *P<0.05 vs. untreated control cells; #P<0.05 vs. TNFα with root extract or TS. ACE2, angiotensin-converting enzyme 2; LPS, lipopolysaccharide; TLR4, toll-like receptor 4; TMPRSS2, transmembrane serine protease 2; TS, taraxasterol.

LPS induces the viability of colorectal cancer cells by targeting TLR4 and ACE2/TMPRSS2 pathways. (A-D) siRNA-mediated knockdown of ACE2 and TMPRSS2. After colorectal cancer cells were transfected with control-siRNA (100 nM) or ACE2-siRNA/TMPRSS2-siRNA (100 nM) for 24 h, the cells were collected for analysis of (A) ACE2 and (C) TMPRSS2 mRNA expression levels by reverse transcription-quantitative PCR, and (B) ACE2 and (D) TMPRSS2 protein expression levels by western blotting. n=3. *P<0.05 vs. control-siRNA. (E) Inhibition of TLR4 and ACE2/TMPRSS2 knockdown decreased the LPS-induced viability of colorectal cancer cells. After colorectal cancer cells were transfected with control-siRNA (100 nM) or ACE2-siRNA/TMPRSS2-siRNA (100 nM) for 24 h, the cells were then incubated with LPS (0.5 µg/ml) for an additional 24 h. In another group, the cells were incubated with CLI095 (10 µM) in the presence or absence of LPS (0.5 µg/ml) for 24 h. Cell viability was analyzed using an MTT assay. n=4. *P<0.05 vs. control-siRNA transfected cells without any other treatment; #P<0.05 vs. control-siRNA transfected cells with LPS treatment. ACE2, angiotensin-converting enzyme 2; LPS, lipopolysaccharide; siRNA, small interfering RNA; TLR4, toll-like receptor 4; TMPRSS2, transmembrane serine protease 2.

Reversal of bacteria-driven colon cancer cell viability with dandelion root extracts and TS. LPS, an endotoxin from gram-negative bacteria, induces the expression of pro-inflammatory cytokines (IL4, IL6 and TNFα) and also ACE2/TMPRSS2 by activating the TLR4-NFκB-p65 pathway, which may induce intestinal cell dysfunction and lead to tumorigenesis of colon cancer. Dandelion root extracts and TS inhibit LPS-induced inflammation and colorectal cancer cell viability by blocking TLR4-NFκB-driven ACE2 and TMPRSS2 pathways. ACE2, angiotensin-converting enzyme 2; LPS, lipopolysaccharide; TLR, toll-like receptor; TMPRSS2, transmembrane serine protease 2; TS, taraxasterol.